
    
      This will be a single center, double-blind, placebo-controlled study in subjects with
      keratosis pilaris affecting both sides of the body.

      Subjects will be screened within 4 weeks of enrollment. Subjects will be seen at the research
      facility on for the baseline visit and will be asked to return to the site on weeks 1, 2, 3
      and 4 for assessments. Test product application will occur for four weeks starting with the
      day of the baseline visit.
    
  